Cargando…

488 Treatment Outcomes in Patients with Extended-Spectrum Beta-lactamase Producing Organisms

Detalles Bibliográficos
Autores principales:	Lee, Eunbae, Butler-Wu, Susan, Pottinger, Paul, Neradilek, Moni Blazej, Jain, Rupali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781772/ http://dx.doi.org/10.1093/ofid/ofu052.354

Ejemplares similares

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

694 Bone and joint infection due to bacteria producing Extended Broad Spectrum Beta lactamase
por: Rouzaud, Claire, et al.
Publicado: (2014)

486 Meropenem and Piperacillin-tazobactam have Comparable Outcomes in Treatment of Bloodstream Infections Caused by Extended Spectrum Beta-lactamase Producing E.coli and Klebsiellae
por: Harris, Patrick, et al.
Publicado: (2014)

479 Clinical outcomes in patients with extended-spectrum-beta-lactamase-producing (ESBL) Enterobacteriaceae bloodstream infections (ESB) treated with carbapenems (CP) and non-carbapenems (NC)
por: Chin, Judy, et al.
Publicado: (2014)

343 Risk Factors for Extended-Spectrum Beta-Lactamase Infection and Evaluation of Carbapenem Use Patterns and Appropriateness in a County Hospital Setting
por: Su, Henry, et al.
Publicado: (2014)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

256 S-649266, a Novel Siderophore Cephalosporin: Mechanisms of enhanced activity and beta-lactamase stability
por: Tsuji, Masakatsu, et al.
Publicado: (2014)

270 SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora
por: Kaleko, Michael, et al.
Publicado: (2014)

717 Clinical characteristics and outcome of metallo-β-lactamase-producing Enterobacter cloacae bacteremia at a tertiary care cancer center in Japan
por: Sasaki, Shugo
Publicado: (2014)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms
por: Mody, Rupal M, et al.
Publicado: (2007)

257 In Vitro Activity of Meropenem/RPX7009, a Carbapenem/β-lactamase Inhibitor Combination Tested Against Contemporary Populations of Enterobacteriaceae and KPC-producing Strains
por: Castanheira, Mariana, et al.
Publicado: (2014)

423 Comparison of pediatric community-acquired, healthcare-associated, and hospital-acquired infections caused by extended-spectrum cephalosporin-resistant Enterobacteriaceae
por: Adler, Amanda, et al.
Publicado: (2014)

Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Fresh Produce
por: Pintor-Cora, Alberto, et al.
Publicado: (2021)

978 Infectious Complications of Extended Peripheral Intravenous Catheters (EPIVs) in a NICU
por: Espinosa, Claudia, et al.
Publicado: (2014)

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
por: Tham, Johan, et al.
Publicado: (2012)

Extended-Spectrum Beta-lactamase Producers: Detection for the Diagnostic Laboratory
por: Sahni, Rani Diana, et al.
Publicado: (2018)

458 Enterococcal Infections (EI) in Kidney Transplant (KT) Recipients – a Four Year Retrospective Review
por: Patel, Tejal, et al.
Publicado: (2014)

455 Enterococcal Infections (EI) in Liver Transplant (LT) Recipients- a 9 year retrospective review
por: Elbatta, Mohammad, et al.
Publicado: (2014)

441 Incidence and Risk Factors for Development of Liver Abscesses in Liver Transplant Recipients with Intra Abdominal Infections - a 10 year retrospective review
por: Aldeiri, Ahmad, et al.
Publicado: (2014)

250 Ceftazidime-avibactam Activity Tested Against a Large Collection of Enterobacteriaceae Isolates Collected in United States (USA) Hospitals in the 2011-2013 Period, Including Organisms Producing KPC- and CTX-M-variants
por: Castanheira, Mariana, et al.
Publicado: (2014)

971 Clinical Spectrum of Group B Streptococcol Cellulitis-Adenitis Syndrome
por: Pretorius, Christopher C., et al.
Publicado: (2014)

1468 Detection of High CSF Levels of (1 → 3)-Beta-D-Glucan in Cryptococcal Meningitis
por: Rhein, Joshua, et al.
Publicado: (2014)

360 Surveillance for Carbapenemase-Producing Bacteria in the Wake of a Nosocomial Outbreak
por: Odom, Robin T., et al.
Publicado: (2014)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

333 Detection of Carbapenemase-Producing Aeromonas hydrophila on Perirectal Surveillance Culture
por: Hughes, Heather Y., et al.
Publicado: (2014)

454 Cytomegalovirus (CMV) Disease after Lung Transplantation (LT) is associated with increased mortality despite Extended Antiviral Prophylaxis
por: Beam, Elena, et al.
Publicado: (2014)

757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin
por: Streifel, Amber, et al.
Publicado: (2014)

1549 Spectrum of Healthcare Engagement in an HIV Primary Care Clinic within the District of Columbia
por: Lagasca, Alicia, et al.
Publicado: (2014)

402 Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
por: Frippiat, Frédéric, et al.
Publicado: (2014)

814 A Prospective Analysis of the Clinical Spectrum of Different Subtypes Human Enterovirus and Human Parechovirus
por: Obihara, Charles, et al.
Publicado: (2014)

Extended-spectrum beta-lactamase-producing Salmonella enteritidis in Trinidad and Tobago.
por: Cherian, B P, et al.
Publicado: (1999)

Efficacy of Admission Screening for Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae
por: Lowe, Christopher F., et al.
Publicado: (2013)

260 Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae
por: Popejoy, Myra, et al.
Publicado: (2014)

351 NDM-1-producing Escherichia coli Isolated from a Case Patient's Environment
por: Buser, Genevieve L., et al.
Publicado: (2014)

349 Surveillance of Carbapenem Resistance and the First Case of NDM-7-producing Klebsiella pneumoniae in the Philippines
por: Chou, Andrew, et al.
Publicado: (2014)

361 Duration of colonization with KPC-producing bacteria at long-term acute care hospitals in Chicago, USA
por: Haverkate, Manon, et al.
Publicado: (2014)

947 Pseudo-outbreak of Carbapenemase producing Enterobacteraciae (CRE) in a low prevalence acute-care hospital
por: Doll, Michelle, et al.
Publicado: (2014)

181 Empiric Coverage of ICU Patients for Infections Due to Beta-lactam Resistant Pseudomonas aeruginosa with Combination Therapy: A Needs Assessment
por: Cawcutt, Kelly, et al.
Publicado: (2014)

1596 Spectrum of Kaposi's sarcoma encountered among HIV-infected patients in an inner-city hospital in the established antiretroviral era
por: Nguyen, Minh Ly, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pnka5f517jhvgspnfbd6saop2c